[go: up one dir, main page]

DK1200121T3 - Fiskevaccine - Google Patents

Fiskevaccine

Info

Publication number
DK1200121T3
DK1200121T3 DK00949768T DK00949768T DK1200121T3 DK 1200121 T3 DK1200121 T3 DK 1200121T3 DK 00949768 T DK00949768 T DK 00949768T DK 00949768 T DK00949768 T DK 00949768T DK 1200121 T3 DK1200121 T3 DK 1200121T3
Authority
DK
Denmark
Prior art keywords
organism
fish
culture
produced
components
Prior art date
Application number
DK00949768T
Other languages
Danish (da)
English (en)
Inventor
Andrew Cartner Barnes
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1200121(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9918591.0A external-priority patent/GB9918591D0/en
Priority claimed from GBGB9923030.2A external-priority patent/GB9923030D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1200121T3 publication Critical patent/DK1200121T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00949768T 1999-08-07 2000-08-07 Fiskevaccine DK1200121T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9918591.0A GB9918591D0 (en) 1999-08-07 1999-08-07 Composition
GBGB9923030.2A GB9923030D0 (en) 1999-09-30 1999-09-30 Composition
PCT/GB2000/002973 WO2001010459A2 (fr) 1999-08-07 2000-08-07 Vaccin

Publications (1)

Publication Number Publication Date
DK1200121T3 true DK1200121T3 (da) 2009-01-12

Family

ID=26315831

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00949768T DK1200121T3 (da) 1999-08-07 2000-08-07 Fiskevaccine

Country Status (10)

Country Link
EP (1) EP1200121B2 (fr)
JP (2) JP4831905B2 (fr)
AT (1) ATE406911T1 (fr)
AU (1) AU6304000A (fr)
CY (1) CY1108781T1 (fr)
DE (1) DE60040153D1 (fr)
DK (1) DK1200121T3 (fr)
ES (1) ES2308987T5 (fr)
PT (1) PT1200121E (fr)
WO (1) WO2001010459A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0317733D0 (en) 2003-07-29 2003-09-03 Novartis Ag Organic compounds
JP2006001849A (ja) * 2004-06-16 2006-01-05 Kochi Univ 魚類類結節症ワクチン
TW201422814A (zh) * 2012-09-10 2014-06-16 Univ Tokyo Nat Univ Corp 針對海產魚之類結節症之ｄｎａ疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403636D0 (sv) * 1994-10-24 1994-10-24 Ewos Ab Vaccine preparation

Also Published As

Publication number Publication date
PT1200121E (pt) 2008-10-01
WO2001010459A3 (fr) 2001-05-10
DE60040153D1 (de) 2008-10-16
ES2308987T5 (es) 2012-08-30
EP1200121B1 (fr) 2008-09-03
JP2011207888A (ja) 2011-10-20
AU6304000A (en) 2001-03-05
ES2308987T3 (es) 2008-12-16
ATE406911T1 (de) 2008-09-15
WO2001010459A2 (fr) 2001-02-15
JP2003506412A (ja) 2003-02-18
EP1200121B2 (fr) 2012-05-09
CY1108781T1 (el) 2014-04-09
EP1200121A2 (fr) 2002-05-02
JP4831905B2 (ja) 2011-12-07

Similar Documents

Publication Publication Date Title
ID22689A (id) Metode untuk mengaktifkan sel-sel yang menunjukan-sifat antigen manusia, sel-sel teraktifkan yang menunjukan sifat antigen manusia, dan penggunaannya
DE69433901D1 (de) Verbindungen und pharmazeutische zusammensetzungen zur behandlung und prophylaxe bakterieller infektionen
EP2067863A3 (fr) Procédés et compositions pour les maladies associées à l'amylose
EP0400958A3 (fr) Vaccins vivants
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
EP2767291A3 (fr) Traitement d'une glycogénose de type II
DE60039078D1 (de) Kleine moleküle zur behandlung von endzündlichen erkrankungen
SG45225A1 (en) A novel physiologically active substance
TR200103149T2 (tr) Virüs ve mikoplazmanın korunması için yöntemler
SE9904581D0 (sv) A novel helicobacter pylori-binding substance and use thereof
KR950700079A (ko) 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
CY1108781T1 (el) Εμβολιο ψαριων
ATE359798T1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
DE60039601D1 (de) Antisense gegen c-myc zur behandlung von polyzystischer nierenkrankheit
EA200100700A1 (ru) Гены и белки и их применение
BRPI0413682A (pt) compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
SE9903534L (sv) Bärare innehållande ett huvudkapsidprotein L1 från humant papillomavirus samt dess användning
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
HK1045712A1 (zh) Fimh粘附素基疫苗
ES2180345T3 (es) Nuevo procedimiento para la crio-conservacion de plantas.
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
ATE295884T1 (de) Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose
PL370854A1 (en) Ee3-protein family and corresponding dna sequences
MX9708615A (es) Terapia de genes animales.
WO2001044278A3 (fr) Preparations d'antigenes